The transplantation and cellular therapy programme of The Ottawa Hospital, performing around 300 stem cell transplants a year at its General Campus.
The Transplant and Cellular Therapy Programme at The Ottawa Hospital cares for patients with diseases of the blood and immune system. According to the hospital's site, the programme carries out roughly three hundred stem cell transplants each year at the General Campus.
The site describes two forms of stem cell transplant: autologous, using the patient's own cells, and allogeneic, using cells from a donor. It also states that patients may receive CAR T-cell therapy, which it describes as an emerging biotherapeutic treatment that uses the patient's own immune cells, known as T-cells, to treat their cancer.
The hospital states that the programme was the first outside the United States to be accredited by the Foundation for the Accreditation of Cellular Therapy, and that as of 2025 it had earned its eighth accreditation, including certification for CAR T-cell therapy. That is the hospital's own statement and is reported here as it appears on the site.
The page names Dr Michael Kennah as a haematology physician, Sheryl McDiarmid as an advanced practice nurse and Tania Baird as programme manager. Outpatient clinics are in Module L at the General Campus, with inpatient and day hospital services on the fifth floor. Telephone lines are given with separate options for pre-transplant, post-transplant and donor enquiries. The page says nothing about cost.
The page describes the patient groups served in broad terms rather than listing individual diseases.
The site states that the programme transplants stem cells taken either from the patient or from a donor, and also gives CAR T-cell therapy made from the patient's own T-cells.
The programme is based at The Ottawa Hospital General Campus. The site states that outpatient clinics are held in Module L and that inpatient and day hospital services are on the fifth floor. Telephone lines are published with separate options for pre-transplant, post-transplant and donor enquiries. The hospital states that the programme holds accreditation from the Foundation for the Accreditation of Cellular Therapy, including certification for CAR T-cell therapy.
The page says nothing about cost. It is part of Ontario's publicly funded hospital system, but the site itself makes no statement about fees.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.